Microbix Biosystems (TSE:MBX) Stock Crosses Below Fifty Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX)’s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.30 and traded as low as C$0.28. Microbix Biosystems shares last traded at C$0.28, with a volume of 70,061 shares trading hands.

Microbix Biosystems Trading Down 5.1%

The business has a 50 day moving average of C$0.30 and a two-hundred day moving average of C$0.27. The firm has a market capitalization of C$38.35 million, a price-to-earnings ratio of -7.78 and a beta of 0.76. The company has a debt-to-equity ratio of 27.69, a quick ratio of 5.57 and a current ratio of 6.89.

Microbix Biosystems (TSE:MBX) last released its quarterly earnings data on Thursday, August 13th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a negative net margin of 31.72% and a negative return on equity of 18.83%. The firm had revenue of C$4.06 million for the quarter. Equities analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

About Microbix Biosystems

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.